CLIENT-PHARMA LTD
Summary
CLIENT-PHARMA LTD was set up on Tuesday, October 8, 2013. Their current partial address is LAURUS HOUSE FIRST AVENUE and the company status is Active.
Credit Score
Latest Accounts Filed:
31/12/2023
Next Set of Accounts Due:
30/09/2025
Company Vitals
Company Name:
CLIENT-PHARMA LTD
Time in Business:
10 years
Company Number:
08723939
Current Status:
Active
Company Category:
Private Limited Company
Country of Origin:
United Kingdom
Principal Activity:
[46460] - Wholesale of pharmaceutical goods
Registered Address:
LAURUS HOUSE FIRST AVENUE
CENTRUM 100
BURTON ON TRENT
STAFFORDSHIRE
ENGLAND
DE14 2WH
Filing History
| Submission | Date | Type |
|---|---|---|
| Accounts with accounts type total exemption full | 2024-03-12 | AA |
| Confirmation statement with updates | 2023-10-03 | CS01 |
| Accounts with accounts type total exemption full | 2023-03-23 | AA |
| Confirmation statement with updates | 2022-10-13 | CS01 |
| Accounts with accounts type total exemption full | 2022-08-08 | AA |
| Confirmation statement with updates | 2021-10-14 | CS01 |
| Accounts with accounts type total exemption full | 2021-08-16 | AA |
| Change registered office address company with date old address new address | 2021-03-24 | AD01 |
| Change to a person with significant control | 2021-02-08 | PSC04 |
| Change person director company with change date | 2021-02-08 | CH01 |
| Confirmation statement with updates | 2020-10-08 | CS01 |
| Accounts with accounts type total exemption full | 2020-09-03 | AA |
| Mortgage create with deed with charge number charge creation date | 2020-06-24 | MR01 |
| Confirmation statement with updates | 2019-10-21 | CS01 |
| Mortgage satisfy charge full | 2019-04-17 | MR04 |
| Accounts with accounts type total exemption full | 2019-04-01 | AA |
| Confirmation statement with updates | 2018-10-09 | CS01 |
| Accounts with accounts type unaudited abridged | 2018-03-13 | AA |
| Confirmation statement with updates | 2017-10-10 | CS01 |
| Mortgage create with deed with charge number charge creation date | 2017-06-21 | MR01 |